Zobrazeno 1 - 1
of 1
pro vyhledávání: '"Attila Cziráki MD.PhD. Professor."'
Autor:
Miguel-Ángel Idoate-Gastearena, David Walker, Victor Aboyans, Helene ABERGEL, Arintaya Phrommintikul, Pawel Bogdanski, Yulia Lukina, Wiesław Bryl, Joao Freitas, Patrick Jourdain, Luis Henrique Wolff Gowdak, Antonio Nicolino, Paul Shiels, Ruxandra Christodorescu, Jassim Al suwaidi, MB, ChB, FACC, FESC, FSCAI, Catalina Arsenescu Georgescu, Michel GALINIER, Philippe Gabriel STEG, Richard Nethononda, Julio Hernández Afonso, Roberto Ferrari, Marcin Gruchala, Cristina Florescu, Wanwarang Wongcharoen, Philippe Gosse, Attila Cziráki MD.PhD. Professor., Philippe Sosner, Michal Tendera, Sergio Bravo Baptista, Fernando Manzur, Juan Jose Gomez Doblas, Vilma Dzenkeviciute, Adelya Hairullina
Publikováno v:
PLoS ONE
PLoS ONE, Vol 7, Iss 5, p e36284 (2012)
Steg, P G, Ferrari, R, Ford, I, Greenlaw, N, Tardif, J-C, Tendera, M, Abergel, H, Fox, K M & CLARIFY Investigators 2012, ' Heart rate and use of beta-blockers in stable outpatients with coronary artery disease ', PLOS ONE, vol. 7, no. 5, e36284 . https://doi.org/10.1371/journal.pone.0036284
PLoS ONE, Vol 7, Iss 5, p e36284 (2012)
Steg, P G, Ferrari, R, Ford, I, Greenlaw, N, Tardif, J-C, Tendera, M, Abergel, H, Fox, K M & CLARIFY Investigators 2012, ' Heart rate and use of beta-blockers in stable outpatients with coronary artery disease ', PLOS ONE, vol. 7, no. 5, e36284 . https://doi.org/10.1371/journal.pone.0036284
Background: Heart rate (HR) is an emerging risk factor in coronary artery disease (CAD). However, there is little contemporary data regarding HR and the use of HR-lowering medications, particularly beta-blockers, among patients with stable CAD in rou
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e7ff39c880860a857b73ac96b99c2bae
http://hdl.handle.net/10044/1/18917
http://hdl.handle.net/10044/1/18917